Skip to main content

Microarray Developer NimbleGen Raises $9M in Latest Financing Round

NEW YORK, Sept 11 – Microarray developer NimbleGen Systems of Madison, Wis., said Tuesday it had raised $9 million in a private round of financing.

The company has raised more than $12.5 million in total.

Investors in the recent round of financing included new investors such as Venture Investors Management, Baird Venture Partners, and State of Wisconsin Investment Board. Previous investors including Skyline Ventures, Tactics II Investments, and The Wisconsin Alumni Research Foundation also participated in the financing round.

NimbleGen produces customized high-density DNA arrays using technology based on digital mirrors. The company said its system is capable of producing specialized arrays in less than four hours.

The company said that it has so far completed the first “pre-manufacturing run” of high-density arrays and that the technology was developing at a “very rapid” pace.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.